Katherine L. Jones

981 total citations
12 papers, 386 citations indexed

About

Katherine L. Jones is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Katherine L. Jones has authored 12 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Katherine L. Jones's work include Melanoma and MAPK Pathways (5 papers), Synthesis of Tetrazole Derivatives (4 papers) and Synthesis and biological activity (2 papers). Katherine L. Jones is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Synthesis of Tetrazole Derivatives (4 papers) and Synthesis and biological activity (2 papers). Katherine L. Jones collaborates with scholars based in United Kingdom, United States and Netherlands. Katherine L. Jones's co-authors include Paul Bamborough, Ann L. Walker, Richard Angell, Stuart Cockerill, Andrew B. Benowitz, John D. Harling, Kathryn J. Smith, Don O. Somers, Chun‐wa Chung and Dramane I. Lainé and has published in prestigious journals such as Nature Communications, Cancer and Journal of Medicinal Chemistry.

In The Last Decade

Katherine L. Jones

12 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katherine L. Jones United Kingdom	10	244	118	103	81	46	12	386
Wenhu Zhan China	14	271 1.1×	111 0.9×	71 0.7×	60 0.7×	27 0.6×	24	380
Jark Böttcher Germany	13	336 1.4×	123 1.0×	126 1.2×	118 1.5×	13 0.3×	23	527
Weiqiong Zuo China	14	316 1.3×	181 1.5×	78 0.8×	26 0.3×	44 1.0×	21	522
Stuart Cockerill United Kingdom	9	190 0.8×	145 1.2×	86 0.8×	80 1.0×	19 0.4×	10	387
Csaba Szántai-Kis Hungary	13	258 1.1×	111 0.9×	79 0.8×	78 1.0×	17 0.4×	24	423
Dao Lentz United States	8	207 0.8×	81 0.7×	39 0.4×	36 0.4×	45 1.0×	10	340
Birgit Zech Germany	6	273 1.1×	94 0.8×	108 1.0×	50 0.6×	55 1.2×	7	427
Cindy Palmer United States	8	158 0.6×	67 0.6×	40 0.4×	25 0.3×	57 1.2×	10	275
Teodora Pene Dumitrescu United States	11	318 1.3×	55 0.5×	46 0.4×	29 0.4×	26 0.6×	20	522
Yasemin Saygıdeğer Türkiye	14	203 0.8×	114 1.0×	136 1.3×	17 0.2×	11 0.2×	37	490

Countries citing papers authored by Katherine L. Jones

Since Specialization

Citations

This map shows the geographic impact of Katherine L. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine L. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine L. Jones more than expected).

Fields of papers citing papers by Katherine L. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine L. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine L. Jones. The network helps show where Katherine L. Jones may publish in the future.

Co-authorship network of co-authors of Katherine L. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine L. Jones. A scholar is included among the top collaborators of Katherine L. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine L. Jones. Katherine L. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Jones, Katherine L., Kevin Stacey, Alicia Evans, et al.. (2025). CD8α and CD70 mark human natural killer cell populations which differ in cytotoxicity. Frontiers in Immunology. 16. 1526379–1526379. 1 indexed citations

Worboys, Jonathan D., Ashley Ambrose, Margherita Bertuzzi, et al.. (2023). TIGIT can inhibit T cell activation via ligation-induced nanoclusters, independent of CD226 co-stimulation. Nature Communications. 14(1). 5016–5016. 31 indexed citations

Robertson, Jack, Marzuq A. Ungogo, Bela E. Bode, et al.. (2021). Direct, Late‐Stage Mono‐N‐arylation of Pentamidine: Method Development, Mechanistic Insight, and Expedient Access to Novel Antiparastitics against Diamidine‐Resistant Parasites. ChemMedChem. 16(22). 3396–3401. 7 indexed citations

Benowitz, Andrew B., Katherine L. Jones, & John D. Harling. (2020). The therapeutic potential of PROTACs. Expert Opinion on Therapeutic Patents. 31(1). 1–24. 36 indexed citations

Burhansstipanov, Linda, et al.. (2016). The experience of treatment barriers and their influence on quality of life in American Indian/Alaska Native breast cancer survivors. Cancer. 123(5). 861–868. 15 indexed citations

Humphreys, P. G., Paul Bamborough, Chun‐wa Chung, et al.. (2016). Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe. Journal of Medicinal Chemistry. 60(2). 695–709. 70 indexed citations

Burhansstipanov, Linda, et al.. (2012). A Comparison of Quality of Life Between Native and Non-Native Cancer Survivors. Journal of Cancer Education. 27(S1). 106–113. 20 indexed citations

Bamborough, Paul, Duncan S. Holmes, Katherine L. Jones, et al.. (2009). p38α Mitogen-Activated Protein Kinase Inhibitors: Optimization of a Series of Biphenylamides to Give a Molecule Suitable for Clinical Progression. Journal of Medicinal Chemistry. 52(20). 6257–6269. 35 indexed citations

Angell, Richard, Paul Bamborough, Jacky B. Buckton, et al.. (2008). Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity. Bioorganic & Medicinal Chemistry Letters. 18(15). 4428–4432. 63 indexed citations

10.

Angell, Richard, Paul Bamborough, Mark J. Bamford, et al.. (2008). Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes. Bioorganic & Medicinal Chemistry Letters. 18(15). 4433–4437. 52 indexed citations

11.

Angell, Richard, Paul Bamborough, Anne Cleasby, et al.. (2007). Biphenyl amide p38 kinase inhibitors 1: Discovery and binding mode. Bioorganic & Medicinal Chemistry Letters. 18(1). 318–323. 32 indexed citations

12.

Angell, Richard, Paul Bamborough, David Brown, et al.. (2007). Biphenyl amide p38 kinase inhibitors 2: Optimisation and SAR. Bioorganic & Medicinal Chemistry Letters. 18(1). 324–328. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact